An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial PneumoniasWilliam D. Travis, Dominique Valeyre, Jürgen Behr et al.|American Journal of Respiratory and Critical Care Medicine|2013Cited by 4.3k
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U. Wells, Daniel F. Dilling, Kevin R. Flaherty et al.|The Lancet Respiratory Medicine|2020Cited by 558
Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosisLynne A. Murray, Erica L. Herzog, David M. Habiel et al.|JCI Insight|2017Cited by 85
Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A French Nationwide Study of Ninety‐Two PatientsÉtienne Crickx, Irène Machelart, Estibaliz Lazaro et al.|Arthritis & Rheumatology|2015Cited by 69
Detection and Early Referral of Patients With Interstitial Lung AbnormalitiesGary M. Hunninghake, Jonathan Goldin, Michel Kadoch et al.|CHEST Journal|2021Cited by 56